Advancing Careers of Investigators in Primary Immune Disorders

PIDTC职业提升核心-摘要 原发性免疫缺陷治疗联盟职业增强核心的目的 （PIDTC）是提供职业发展，将加强在临床博士后水平的教育。PIDTC 代表了一个独特的利益相关者联盟，致力于研究最佳方法， 治疗罕见的原发性免疫缺陷（PID）。我们有一个强大的培训计划，以确定和 培养需要和重视接触罕见疾病方法学的学员，特别是对以下方面感兴趣的学员： PID。PIDTC职业提升计划自2009年以来一直存在，当时第一笔培训赠款 被提供。自那时以来，已经颁发了20个奖项，几乎所有获奖者都继续在罕见的 在学术环境中研究疾病大多数人从事研究工作。一项核心努力是针对 提供培训赠款，以支持和激发对PID研究的兴趣。此外，我们还提供以下指导： 职业生涯，对写作的反馈，网络和机会与RDCRN接口。我们的年会 提供机会与教师在该领域的参与，我们积极推进通过相关的职业生涯 教育日在会上。这项申请将扩大工作从事研究员和年轻的教师在罕见的 疾病的方法，并提供一个有经验的教师网络，以促进和鼓励职业生涯， PID的治疗我们有三个具体目标来推进这一重要事业：1）选择最高质量的 候选人的研究支持在原发性免疫缺陷; 2）纳入学员和初级学院 联合会网站到PIDTC活动，以提高他们的教育和网络机会，以及3）提供 罕见病工作的方法学教育和外联工作。这一综合培训计划促进了 与代表我们服务的选区的患者倡导团体的关系。该计划还擅长 并将不同背景的教师聚集在一起，以确保移植和其他治疗方式 从感染性疾病、血液学和免疫学的角度进行了研究。之多样 在PIDTC代表了一种模式，通过新的多学科方法推进护理锻造 合作。

PIDTC Career Enhancement Core – Abstract The purpose of the Career Enhancement Core of the Primary Immune Deficiency Treatment Consortium (PIDTC) is to provide career development that will enhance education at the clinical post-doctoral level. PIDTC represents a unique consortium of stakeholders committed to investigating the optimal approach to the management of rare primary immune deficiencies (PID). We have a robust training program to identify and nurture trainees who need and value exposure to rare disease methodology and specifically with an interest in PID. The PIDTC Career Enhancement program has been in existence since 2009 when the first Training Grants were offered. Twenty awards have been made since that time and nearly all awardees have continued in rare disease work in an academic setting. Most have pursued research careers. A central effort is directed at providing Training Grants to support and stimulate interest in PID research. We additionally offer guidance on careers, feedback on writing, networking and opportunities to interface with the RDCRN. Our annual meeting offers opportunities to engage with faculty in the field and we proactively advance careers through the associated Education Day at the meeting. This application will extend the work engaging fellows and young faculty in rare disease methodology and provide a network of experienced faculty to promote and encourage a career in treatment of PID. We have three Specific Aims to advance this important cause: 1) select the highest quality candidates for research support in Primary Immune Deficiencies; 2) Incorporate Trainees and Junior Faculty of consortium sites into PIDTC activities to enhance their education and networking opportunities, and 3) provide education on methodology and outreach efforts for rare disease work. This integrated training program fosters relationships with patient advocacy groups who represent the constituency we serve. This program also excels and bringing together faculty of diverse backgrounds to ensure that transplant and other treatment modalities are examined from the perspective of infectious diseases, hematologic and immunologic angles. The diversity in PIDTC represents a model for advancing care through novel multidisciplinary approaches forged collaboratively.